| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000041434 |
| Receipt No. | R000047203 |
| Scientific Title | Diagnostic accuracy of chest X-ray, CT, and interferon-gamma release assay to detect the miliary tuberculosis: systematic review and meta-analysis |
| Date of disclosure of the study information | 2020/08/18 |
| Last modified on | 2020/08/17 (Ver. 1) |
| Basic information | ||
| Public title | Diagnostic accuracy of chest X-ray, CT, and interferon-gamma release assay to detect the miliary tuberculosis: systematic review and meta-analysis | |
| Acronym | Diagnostic accuracy of chest X-ray, CT, and interferon-gamma release assay to detect the miliary tuberculosis: systematic review and meta-analysis | |
| Scientific Title | Diagnostic accuracy of chest X-ray, CT, and interferon-gamma release assay to detect the miliary tuberculosis: systematic review and meta-analysis | |
| Scientific Title:Acronym | Diagnostic accuracy of chest X-ray, CT, and interferon-gamma release assay to detect the miliary tuberculosis: systematic review and meta-analysis | |
| Region |
|
|
| Condition | ||
| Condition | Milliary tuberculosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Identify the diagnostic accuracy of chest X-ray, CT, and interferon-gamma release assay to detect the miliary tuberculosis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | True positives, false positives, true negatives, and false negatives. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients suspected of miliary tuberculosis infection | |||
| Key exclusion criteria | None | |||
| Target sample size | 0 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama Municipal Citizen's Hospital | ||||||
| Division name | Department of Respiratory Medicine | ||||||
| Zip code | 221-0855 | ||||||
| Address | 1-1 Mitsuzawa Nishimachi Kanagawa-ku, Yokohama-shi, Kanagawa, Japan | ||||||
| TEL | 045-316-4580 | ||||||
| me19003@s.okayama-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama Municipal Citizen's Hospital | ||||||
| Division name | Department of Respiratory Medicine | ||||||
| Zip code | 221-0855 | ||||||
| Address | 1-1 Mitsuzawa Nishimachi Kanagawa-ku, Yokohama-shi, Kanagawa, Japan | ||||||
| TEL | 045-316-4580 | ||||||
| Homepage URL | |||||||
| me19003@s.okayama-u.ac.jp | |||||||
| Sponsor | |
| Institute | Yokohama Municipal Citizen's Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital |
| Address | 1-1 Mitsuzawa Nishimachi Kanagawa-ku, Yokohama-shi, Kanagawa, Japan |
| Tel | 045-316-4580 |
| me19003@s.okayama-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Participants
The target participants are suspected of miliary tuberculosis. Target condition The target condition is miliary tuberculosis. Setting Any type of settings is included. Index test The index test being investigated is chest X-ray, CT, and interferon-gamma release assay. Reference standard The reference standard is the identification of Mycobacterium tuberculosis by anti-acid culture or PCR of blood, urine, lower respiratory tract samples, and other tissues. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047203 |